Galenea Corp. - Product Pipeline Review - 2012 - New Market Study Published

New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

by Bill Thompson

(WireNews+Co) - Boston, MA - 05 March 2013

Global Market Direct's pharmaceuticals report, "Galenea Corp. - Product Pipeline Review - 2012" provides data on the Galenea Corp.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Galenea Corp.'s corporate website, SEC filings, investor presentations and featured press releases, both from Galenea Corp. and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- Galenea Corp. - Brief Galenea Corp. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Galenea Corp. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Galenea Corp. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Galenea Corp.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

View Full Report Details (http://www.fastmr.com/prod/530065_galenea_corp_product_pipeline_review_2012.aspx?afid=201) (http://www.fastmr.com/prod/530065_galenea_corp_product_pipeline_review_2012.aspx?afid=201)

Reasons to buy

- Evaluate Galenea Corp.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Galenea Corp. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Galenea Corp.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Galenea Corp..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Galenea Corp. and identify potential opportunities in those areas.

Fast Market Research (http://www.fastmr.com?afid=201) is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget.  For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.